[ad_1]
Village Farms International, Inc. VFF announced the launch in Germany of cannabis products grown by its Canadian Cannabis business (wholly owned subsidiary, Pure Sunfarms). The German launch is in partnership with IUVO Therapeutics GmbH, an importer, marketer and distributor of medical cannabis for the German market. IUVO expects Pure Sunfarms’ Pink Kush to be available to German patients in the coming days.
“Commencing cannabis product sales in Germany is another meaningful step forward in our international cannabis strategy,” stated Michael DeGiglio, CEO, Village Farms. “Robust consumer demand for our differentiated products, led by the same Pink Kush dried flower that will be available to German consumers, drove a ten-fold increase in Village Farms’ cannabis exports to Australia during 2022. Together with Australia and Israel, Germany adds a third international market where we have demonstrated our ability to respond to rigorous testing standards and deliver an exceptional product to medical consumers. Pursuing more profitable export opportunities is an important part of our growth strategy, while we continue to delight Canadian consumers with our consistent, high quality, British Columbia-grown flower.”
Mandesh Dosanjh, president and CEO, Pure Sunfarms, stated: “The launch of Pure Sunfarms grown cannabis products in Germany – the largest market in Europe – means German patients will soon have access to one of Canada’s top brands, starting with the country’s number one selling dried flower product, our own Pink Kush. Originally offered in Canada in June 2020, Pure Sunfarms’ Pink Kush is a major contributor to Village Farms’ Canadian Cannabis business catapulting to the overall number two market share position nationally.”
Photo by Esteban López on Unsplash
Related News
ROSE LifeScience, Entourage And The Boston Beer Company Team Up And Launch Cannabis-Infused Iced Tea
Pure Sunfarms’ Soar Cannabis Brand Expands Limited Batch Collection With 1g Pre-Roll Offering
Village Farms International: Analyst Reduces Price Target But Maintains Overweight After Q4 Results
[ad_2]
Source link